Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maud Voldoire
Observed name:
M. Voldoire
Institution:
Hôpital privé du Confluent
Observed institutions:
Inserm,
Centre Hospitalier Universitaire de Nantes,
Université de Poitiers,
Centre Hospitalier Universitaire de Poitiers,
Hôpital privé du Confluent,
Centre Hospitalier Départemental Vendée,
Nantes Université
show all 7
ORCID:
0009-0006-3351-4309
Observed ORCID:
0009-0006-3351-4309
OpenAlex ID:
A5041250094
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study
2015
·
A. Lassalle
, P. Thomaré
, et al.
·
Annals of Oncology
·
51
Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene
2011
·
Caroline Mayeur-Rousse
, Nathalie Sorel
, et al.
·
Leukemia Research
·
11
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
2022
·
Kamel Laribi
, Alix Baugier de Materre
, et al.
·
HemaSphere
·
10
Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience
2016
·
J. Bourcier
, T. Gastinne
, et al.
·
Annals of Hematology
·
10
Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML)
2018
·
Christophe Desterke
, Maud Voldoire
, et al.
·
Experimental Hematology
·
8
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?
2017
·
Elsa Lestang
, Pierre Peterlin
, et al.
·
European Journal Of Haematology
·
5
ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia
2023
·
Seda Baykal-Köse
, Maud Voldoire
, et al.
·
Turkish Journal of Hematology
·
4
PDF
Similarity of fractionated versus single dose(s) of gemtuzumab ozogamicin as part of the MIDAM salvage regimen in relapsed/refractory acute myeloid leukemia patients
2016
·
Pierre Peterlin
, Thierry Guillaume
, et al.
·
Seminars in Hematology
·
4
Multiple brain lesions in a patient with relapsed hairy cell leukemia: a case report and review of the literature
2025
·
Katell Le Dû
, Jacques Delaunay
, et al.
·
CNS Oncology
·
2
PDF
The Cell Surface NADH Oxidase ENOX2 Is Highly Expressed in Chronic Myeloid Leukemia (CML): a Redox Protein As a Secreted Surrogate Biomarker and Druggable Target
2016
·
Seda Baykal
, Maud Voldoire
, et al.
·
Blood
·
1
ETS1 Expression Is Upregulated in Chronic Myeloid Leukemia (CML) and the ETS1 Transcriptional Program Correlates with Disease Progression Towards Blast Crisis
2016
·
Christophe Desterke
, Maud Voldoire
, et al.
·
Blood
·
1
Second-Generation Relative Donor for T-Replete Haplo-Identical Allogeneic Stem Cell Transplantation with High-Dose Post-Transplant Cyclophosphamide: Towards Disappearance of the HLA Barrier
2015
·
Patrice Chevallier
, Pierre Peterlin
, et al.
·
Blood
·
1
No Advantages of Fractionated Versus Single Dose(s) of Gemtuzumab Ozogamicin (GO) As Part of the Midam Salvage Regimen in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients
2015
·
Pierre Peterlin
, Thierry Guillaume
, et al.
·
Blood
·
1
Mantle cells lymphoma: standards and news
2015
·
Ronan Le Calloch
, Maud Voldoire
, et al.
·
Hématologie
·
1
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia. a randomized national fi-LMC comparative trial of two therapeutic strategies.
2025
·
Emilie Cayssials
, Jose Torregrosa
, et al.
·
Blood
PDF
Allogeneic Stem Cell Transplantation for Primary or Secondary Myelofibrosis: A Retrospective Intent-to-Treat Analysis and Impact of Mutational Status and JAK1/2 Inhibitor Ruxolitinib Prescription in Patients Who Cannot Proceed to Transplantation
2015
·
Elsa Lestang
, Pierre Peterlin
, et al.
·
Blood
Post-Transplant Cyclophosphamide (PTCY) Versus Anti-Thymoglobulin (ATG) As Part of the Gvhd Prophylaxis for Fludarabine/Clofarabine/Busulfan Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT): Influence on Early Outcomes
2015
·
Alice Garnier
, Thierry Guillaume
, et al.
·
Blood
Important Prognostic Impact of Early Monocytes Recovery after Reduced Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Adults
2014
·
Amandine Le Bourgeois
, Thierry Guillaume
, et al.
·
Blood
Show more works
View as search
Works count:
18
Citation count:
110
H-index:
5
I10-index:
4
Year
Topic
Type